GREGORY LARSON: Open Payments
NPI 1134577448 · SPEARFISH, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 32 payments from 13 companies in 2025. Trend: 2023 $252 · 2024 $435 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $259 |
| Regeneron Healthcare Solutions, Inc. | 4 | $129 |
| ABBVIE INC. | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Incyte Corporation | 3 | $54 |
| UCB, Inc. | 1 | $33 |
| Organon LLC | 3 | $30 |
| KYOWA KIRIN, INC. | 1 | $30 |
| PFIZER INC. | 1 | $23 |
Products named: DUPIXENT, TREMFYA, OPZELURA, SKYRIZI, Bimzelx, POTELIGEO, Rhapsido, COSENTYX.
Industry payments across SD — which companies pay providers there.
